TW200504186A - Cyanopyridone derivatives - Google Patents

Cyanopyridone derivatives

Info

Publication number
TW200504186A
TW200504186A TW093104311A TW93104311A TW200504186A TW 200504186 A TW200504186 A TW 200504186A TW 093104311 A TW093104311 A TW 093104311A TW 93104311 A TW93104311 A TW 93104311A TW 200504186 A TW200504186 A TW 200504186A
Authority
TW
Taiwan
Prior art keywords
liquid crystal
polymers
cyanopyridone derivatives
cyanopyridone
derivatives
Prior art date
Application number
TW093104311A
Other languages
English (en)
Chinese (zh)
Inventor
Louise Diane Farrand
Michael Heckmeier
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of TW200504186A publication Critical patent/TW200504186A/zh

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84Nitriles
    • C07D213/85Nitriles in position 3
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K19/00Liquid crystal materials
    • C09K19/04Liquid crystal materials characterised by the chemical structure of the liquid crystal components, e.g. by a specific unit
    • C09K19/06Non-steroidal liquid crystal compounds
    • C09K19/34Non-steroidal liquid crystal compounds containing at least one heterocyclic ring
    • C09K19/3441Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom
    • C09K19/3483Non-steroidal liquid crystal compounds containing at least one heterocyclic ring having nitrogen as hetero atom the heterocyclic ring being a non-aromatic ring
    • GPHYSICS
    • G02OPTICS
    • G02FOPTICAL DEVICES OR ARRANGEMENTS FOR THE CONTROL OF LIGHT BY MODIFICATION OF THE OPTICAL PROPERTIES OF THE MEDIA OF THE ELEMENTS INVOLVED THEREIN; NON-LINEAR OPTICS; FREQUENCY-CHANGING OF LIGHT; OPTICAL LOGIC ELEMENTS; OPTICAL ANALOGUE/DIGITAL CONVERTERS
    • G02F1/00Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics
    • G02F1/01Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour 
    • G02F1/13Devices or arrangements for the control of the intensity, colour, phase, polarisation or direction of light arriving from an independent light source, e.g. switching, gating or modulating; Non-linear optics for the control of the intensity, phase, polarisation or colour  based on liquid crystals, e.g. single liquid crystal display cells
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2323/00Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition
    • CCHEMISTRY; METALLURGY
    • C09DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
    • C09KMATERIALS FOR MISCELLANEOUS APPLICATIONS, NOT PROVIDED FOR ELSEWHERE
    • C09K2323/00Functional layers of liquid crystal optical display excluding electroactive liquid crystal layer characterised by chemical composition
    • C09K2323/02Alignment layer characterised by chemical composition

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Nonlinear Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Liquid Crystal Substances (AREA)
  • Pyridine Compounds (AREA)
  • Polarising Elements (AREA)
  • Cosmetics (AREA)
  • Electroluminescent Light Sources (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
TW093104311A 2003-02-22 2004-02-20 Cyanopyridone derivatives TW200504186A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP03003968 2003-02-22

Publications (1)

Publication Number Publication Date
TW200504186A true TW200504186A (en) 2005-02-01

Family

ID=32892857

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093104311A TW200504186A (en) 2003-02-22 2004-02-20 Cyanopyridone derivatives

Country Status (7)

Country Link
US (1) US7442475B2 (enExample)
EP (1) EP1594842A1 (enExample)
JP (1) JP2006523184A (enExample)
KR (1) KR20050109505A (enExample)
CN (1) CN1753873A (enExample)
TW (1) TW200504186A (enExample)
WO (1) WO2004074253A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0515505A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados heterocìclicos e sua utilização como inibidores da estearoil-coa desaturase
AU2005286728A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as mediators of stearoyl-CoA desaturase
WO2006101521A2 (en) 2004-09-20 2006-09-28 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
EP1799667B1 (en) 2004-09-20 2013-03-20 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as therapeutic agents
AR051026A1 (es) 2004-09-20 2006-12-13 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa
CA2580845A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
EP1799664A1 (en) 2004-09-20 2007-06-27 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
LU91146B1 (en) 2005-03-10 2006-09-11 Ipalco Bv Device for suppying preconditioned air to an aircraft on the ground
CA2618646A1 (en) 2005-06-03 2007-11-15 Xenon Pharmaceuticals Inc. Aminothiazole derivatives as human stearoyl-coa desaturase inhibitors
AU2009285584B2 (en) * 2008-08-29 2015-04-02 Treventis Corporation Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system
US8257639B2 (en) * 2009-09-22 2012-09-04 Kent State University Method of making stimuli responsive liquid crystal-polymer composite fibers
US8168084B2 (en) * 2009-12-18 2012-05-01 Vanderbilt University Polar nematic compounds
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
US9133123B2 (en) 2010-04-23 2015-09-15 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
WO2015057655A1 (en) 2013-10-14 2015-04-23 Eisai R&D Management Co., Ltd. Selectively substituted quinoline compounds
MY192489A (en) 2013-10-14 2022-08-23 Eisai R&D Man Co Ltd Selectively substituted quinoline compounds
KR102392188B1 (ko) 2014-10-27 2022-04-28 삼성전자주식회사 편광 필름용 조성물, 편광 필름 및 표시 장치
US20170351130A1 (en) * 2014-12-19 2017-12-07 Merck Patent Gmbh Light modulation element
CN108341771B (zh) * 2017-01-21 2021-05-11 浙江九洲药业股份有限公司 一种3-氰基-2,6-二羟基吡啶钠水合物的制备方法
CN109705343B (zh) * 2018-12-12 2020-11-06 上海交通大学 薁基共价三嗪骨架及其应用
CN112980225A (zh) * 2021-02-25 2021-06-18 张家港莱拓新材料科技有限公司 一种新型可聚合介晶混合物涂料及其应用
CN113292576B (zh) * 2021-06-08 2023-05-30 山西大学 一类基于三苯胺的光热小分子及其制备方法和应用
MX2024000313A (es) 2021-07-09 2024-03-06 Plexium Inc Compuestos de arilo y composiciones farmaceuticas que modulan la ikzf2.

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0180188B1 (en) * 1984-10-30 1992-04-15 Otsuka Pharmaceutical Co., Ltd. A composition for increasing the anti-cancer activity of an anti-cancer compound
US4864021A (en) * 1984-10-30 1989-09-05 Otsuka Pharmaceutical Co., Ltd. 5-fluorouracil derivatives
JPS61233672A (ja) * 1985-04-08 1986-10-17 Chisso Corp 正の誘電異方性を示すピリジン誘導体
JPS61204168A (ja) * 1985-03-06 1986-09-10 Chisso Corp ピリジン誘導体
US4684477A (en) * 1985-03-06 1987-08-04 Chisso Corporation Pyridine derivatives and their use in liquid crystals
JPS6219568A (ja) * 1985-07-18 1987-01-28 Chisso Corp 新規ピリジン誘導体
JPH0625119B2 (ja) * 1985-04-22 1994-04-06 チッソ株式会社 新規ピリジン誘導体
JPH0674248B2 (ja) * 1985-12-20 1994-09-21 チッソ株式会社 含窒素化合物
DE3786834T2 (de) * 1986-04-30 1994-03-03 Otsuka Pharma Co Ltd 5-Fluoro-Uracil-Derivate.
JPH0688996B2 (ja) * 1986-07-24 1994-11-09 大塚製薬株式会社 5−フルオロウラシル誘導体
JPS63201127A (ja) * 1987-02-17 1988-08-19 Otsuka Pharmaceut Co Ltd 5−フルオロウラシル誘導体を含有する制癌剤
JPH0749422B2 (ja) * 1986-12-25 1995-05-31 大塚製薬株式会社 5−フルオロ−5,6−ジヒドロウラシル誘導体
WO1988007992A1 (fr) 1987-04-07 1988-10-20 Pavljuchenko Assya I Derives cristallins liquides de 2,5-pyridine disubstituee a usage de constituants de materiau cristallin liquide, et materiau cristallin liquide
JPH02500274A (ja) * 1987-12-30 1990-02-01 パフルユチェンコ,アススヤ イオシフォフナ 液晶材料の成分としての2,5‐二置換ピリジンの液晶誘導体および液晶材料
JP2700263B2 (ja) * 1988-12-16 1998-01-19 大塚製薬株式会社 5―フルオロウラシル誘導体の製造法
JPH04288058A (ja) * 1990-07-11 1992-10-13 Fuji Photo Film Co Ltd フェニルピリジン化合物及びこれを含有する液晶組成物
JPH04217665A (ja) 1990-10-26 1992-08-07 Fuji Photo Film Co Ltd 分岐を有するフェニルピリジン化合物及びこれを含有する液晶組成物
JP3060331B2 (ja) * 1991-07-18 2000-07-10 コニカ株式会社 カラーフィルターアレイ素子
JPH0551536A (ja) * 1991-08-26 1993-03-02 Mitsubishi Kasei Corp パーフルオロアルキル基含有アゾ系色素
US5578419A (en) * 1991-12-12 1996-11-26 Mitsui Toatsu Chemicals, Incorporated Dyes for color filters, and photosensitive resist resin composition containing the same
JPH07207169A (ja) * 1994-01-12 1995-08-08 Mitsui Toatsu Chem Inc 偏光フィルム用アゾ系色素及びこれを用いた偏光フィルム
GB9922136D0 (en) * 1999-09-20 1999-11-17 Avecia Ltd Compounds, compositions and use
US6664025B2 (en) * 2002-02-12 2003-12-16 Kodak Polychrome Graphics Llc Visible radiation sensitive composition

Also Published As

Publication number Publication date
US7442475B2 (en) 2008-10-28
KR20050109505A (ko) 2005-11-21
CN1753873A (zh) 2006-03-29
US20060165916A1 (en) 2006-07-27
EP1594842A1 (en) 2005-11-16
WO2004074253A1 (en) 2004-09-02
JP2006523184A (ja) 2006-10-12

Similar Documents

Publication Publication Date Title
TW200504186A (en) Cyanopyridone derivatives
ATE385251T1 (de) Substituierte anthracene
WO2004065523A8 (en) Ionic mesogenic compounds
TW200638136A (en) Liquid crystal display device and electronic apparatus
TW566564U (en) Back light module and liquid crystal display using the same
JP2009541881A5 (enExample)
DE60201213D1 (de) Polymerisierbares Flüssigkristallmaterial
AU2003212659A1 (en) Backlight assembly using the same and liquid crystal display device
TW200628899A (en) Liquid crystal display and electronic apparatus
AU2003244204A1 (en) Liquid crystal display device
ATE447001T1 (de) Mesogene verbindungen, medium für elektrooptische anzeige sowie elektrooptische anzeige
ATE531780T1 (de) Kalamitische mesogene verbindungen
AU2003231534A1 (en) Liquid crystal display device
AU2003272062A1 (en) Electro-optical circuitry having integrated connector and methods for the production thereof
AU2003242010A1 (en) Liquid crystal display device
DE502006006516D1 (de) Sicherheitsdokument mit integriertem schaltkreis und integriertem anzeigeelement
AU2003208038A1 (en) Backlight assembly and liquid crystal display apparatus having the same
AU2003209644A1 (en) Electrooptical display with changeable pictures
TW547668U (en) Liquid crystal display and backlit module used therein
ATE391159T1 (de) Polymerisierbare mesogene cyclohexylphenylderivate
TW576511U (en) Backlight module and the housing thereof
TW200720267A (en) Chiral compounds
AU2003281114A1 (en) Polarizing plate having optically anisotropic layer formed from liquid crystal molecules
AUPS301902A0 (en) Polarising liquid crystal device for security documents
DE60324799D1 (de) Em material bestehende schuppen